United Kingdom
Welcome to EMMAC Investor Relations
EMMAC Life Sciences: Corporate Profile
EMMAC Life Sciences Limited is Europe’s largest independent cannabis company, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. With a unique supply and distribution network throughout Europe, EMMAC’s vision is to bring the life-enhancing potential of cannabis to the people who need it.
Read the Press Release
Andina Acquisition Corp. III and EMMAC Life Sciences Limited Announce Signing of Non-Binding Letter of Intent for Business Combination
22nd July 2020 EMMAC is the Largest Independent European Cannabis Company with Low-Cost Cultivation, EU-GMP Manufacturing and Processing, and an Import / Distribution Network in
Medalchemy receives licence for cultivation of medical cannabis. Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract
28 July 2020, London. EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that Medalchemy, the Group’s Good Manufacturing Practice (“GMP”)
View the Investor Presentation
Investor Call
24th July 2020
Investor Enquiries
Fill in the form, below, to register you interest in EMMAC Life Sciences Group